Home Spirometer Market Size, Share, and Trends 2024 to 2034

The global home spirometer market size was USD 1.17 billion in 2023, estimated at USD 1.21 billion in 2024 and is anticipated to reach around USD 1.74 billion by 2034, expanding at a CAGR of 3.70% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 3577
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Home Spirometer Market 

5.1. COVID-19 Landscape: Home Spirometer Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Home Spirometer Market, By Type

8.1. Home Spirometer Market Revenue and Volume Forecast, by Type, 2024-2034

8.1.1. Hand-Held

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Table-Top

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Home Spirometer Market, By Technology

9.1. Home Spirometer Market Revenue and Volume Forecast, by Technology, 2024-2034

9.1.1. Volume Measurement

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Flow Measurement

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Home Spirometer Market, By Application 

10.1. Home Spirometer Market Revenue and Volume Forecast, by Application, 2024-2034

10.1.1. Asthma

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. COPD

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Home Spirometer Market, By End User 

11.1. Home Spirometer Market Revenue and Volume Forecast, by End User, 2024-2034

11.1.1. Hospitals and Clinics

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Home Healthcare

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Others

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Home Spirometer Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.1.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.1.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.1.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.1.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.2.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.7.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.3.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.7.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.7.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.5.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)

12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

12.5.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

Chapter 13. Company Profiles

13.1. Vitalograph Ltd.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. MIR (Medical International Research)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Schiller AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Nihon Kohden Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. NDD Medical Technologies

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Contec Medical Systems Co., Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Microlife Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Fysiomed

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. CareFusion Corporation (acquired by BD)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. SDI Diagnostics

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client